In the five years of its existence, the Czech national registry of multiple sclerosis patients, ReMuS, has become an invaluable source of data for clinical practice and research. This article provides an overview of how the registry has evolved since its inception in 2013 and the importance of the data collected for improving care for multiple sclerosis patients. ReMuSset up by the IMPULS Foundation in collaboration with a professional society, now includes data from more than 13,000 patients at all stages of the disease and regularly provides key information on demographics, disease progression, treatment efficacy and safety to help doctors decide on the most appropriate therapy. The results obtained from the registry reveal not only trends in the use of medicines, but also the evolution of diagnostic procedures and treatment availability in the Czech Republic.
prof. Dana Horáková, MD, Ph.D.
General University Hospital in Prague
You can read the full article in Czech on the magazine's website Neurology for practice.
